Safety Could Differentiate Nkarta’s CAR-NK Cell Therapy

Allogeneic Therapy Can Be Re-Dosed

 
• By Andrew McConaghie

Nkarta has updated its early results for its natural killer cell therapy, where it has shown promising efficacy and potentially superior safety to existing CAR-Ts.

NK Cell
Harnessing the power of natural killer cells could prove to be superior to CAR-Ts, especially on safety. • Source: Shutterstock

More from Business

More from Scrip